chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Blood iron, Blood iron increased, Blood pressure increased, Blood pressure measurement, COVID-19
Clinical narrative: tested positive with Covid symptoms (omicron was mostly in area); tested positive with Covid symptoms (omicron was mostly in area); hyperthyroidism; heart rate elevated; elevated white cell blood count; elevated iron; her heartrate elevated along with bp; Hypothyroid; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A 46 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "hashimoto" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing), notes: controlled with meds for years. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Dec2021, outcome "unknown" and all described as "tested positive with Covid symptoms (omicron was mostly in area)"; HYPOTHYROIDISM (medically significant) with onset 2021, outcome "unknown", described as "Hypothyroid"; HYPERTHYROIDISM (medically significant) with onset May2021, outcome "unknown", described as "hyperthyroidism"; HEART RATE INCREASED (non-serious) with onset May2021, outcome "unknown", described as "heart rate elevated"; WHITE BLOOD CELL COUNT INCREASED (non-serious) with onset 2021, outcome "unknown", described as "elevated white cell blood count"; BLOOD IRON INCREASED (non-serious) with onset 2021, outcome "unknown", described as "elevated iron"; BLOOD PRESSURE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "her heartrate elevated along with bp".The patient underwent the following laboratory tests and procedures: blood iron: (unspecified date) elevated; blood pressure measurement: (unspecified date) elevated; heart rate: (unspecified date) elevated; investigation: (unspecified date) hypothyroid; sars-cov-2 test: (20Dec2021) positive; white blood cell count: (unspecified date) elevated. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: The reported COVID-19 positive after COVID-19 immunization is considered drug ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration and based on the current available limited information in the case provided, the causal association between the events Hypothyroidism, Hyperthyroidism, Heart rate increased, White blood cell count increased, Blood iron increased, Blood pressure increased and the use of suspect product BNT162B2 cannot be fully excluded  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Sex: F
Vaccine: COVID19
Symptoms: Drug ineffective, Heart rate, Heart rate increased, Hyperthyroidism, Hypothyroidism
Clinical narrative: tested positive with Covid symptoms (omicron was mostly in area); tested positive with Covid symptoms (omicron was mostly in area); hyperthyroidism; heart rate elevated; elevated white cell blood count; elevated iron; her heartrate elevated along with bp; Hypothyroid; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A 46 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "hashimoto" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing), notes: controlled with meds for years. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Dec2021, outcome "unknown" and all described as "tested positive with Covid symptoms (omicron was mostly in area)"; HYPOTHYROIDISM (medically significant) with onset 2021, outcome "unknown", described as "Hypothyroid"; HYPERTHYROIDISM (medically significant) with onset May2021, outcome "unknown", described as "hyperthyroidism"; HEART RATE INCREASED (non-serious) with onset May2021, outcome "unknown", described as "heart rate elevated"; WHITE BLOOD CELL COUNT INCREASED (non-serious) with onset 2021, outcome "unknown", described as "elevated white cell blood count"; BLOOD IRON INCREASED (non-serious) with onset 2021, outcome "unknown", described as "elevated iron"; BLOOD PRESSURE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "her heartrate elevated along with bp".The patient underwent the following laboratory tests and procedures: blood iron: (unspecified date) elevated; blood pressure measurement: (unspecified date) elevated; heart rate: (unspecified date) elevated; investigation: (unspecified date) hypothyroid; sars-cov-2 test: (20Dec2021) positive; white blood cell count: (unspecified date) elevated. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: The reported COVID-19 positive after COVID-19 immunization is considered drug ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration and based on the current available limited information in the case provided, the causal association between the events Hypothyroidism, Hyperthyroidism, Heart rate increased, White blood cell count increased, Blood iron increased, Blood pressure increased and the use of suspect product BNT162B2 cannot be fully excluded  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Sex: F
Vaccine: COVID19
Symptoms: Investigation, SARS-CoV-2 test, White blood cell count, White blood cell count increased
Clinical narrative: tested positive with Covid symptoms (omicron was mostly in area); tested positive with Covid symptoms (omicron was mostly in area); hyperthyroidism; heart rate elevated; elevated white cell blood count; elevated iron; her heartrate elevated along with bp; Hypothyroid; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  A 46 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "hashimoto" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing), notes: controlled with meds for years. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Dec2021, outcome "unknown" and all described as "tested positive with Covid symptoms (omicron was mostly in area)"; HYPOTHYROIDISM (medically significant) with onset 2021, outcome "unknown", described as "Hypothyroid"; HYPERTHYROIDISM (medically significant) with onset May2021, outcome "unknown", described as "hyperthyroidism"; HEART RATE INCREASED (non-serious) with onset May2021, outcome "unknown", described as "heart rate elevated"; WHITE BLOOD CELL COUNT INCREASED (non-serious) with onset 2021, outcome "unknown", described as "elevated white cell blood count"; BLOOD IRON INCREASED (non-serious) with onset 2021, outcome "unknown", described as "elevated iron"; BLOOD PRESSURE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "her heartrate elevated along with bp".The patient underwent the following laboratory tests and procedures: blood iron: (unspecified date) elevated; blood pressure measurement: (unspecified date) elevated; heart rate: (unspecified date) elevated; investigation: (unspecified date) hypothyroid; sars-cov-2 test: (20Dec2021) positive; white blood cell count: (unspecified date) elevated. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: The reported COVID-19 positive after COVID-19 immunization is considered drug ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration and based on the current available limited information in the case provided, the causal association between the events Hypothyroidism, Hyperthyroidism, Heart rate increased, White blood cell count increased, Blood iron increased, Blood pressure increased and the use of suspect product BNT162B2 cannot be fully excluded  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Cough, Dyspnoea, Eyelid margin crusting, Fatigue
Clinical narrative: Rapid heart rate, explosive cough that made me pee, chest pain, extreme fatigue, i felt like I had liquid in my lungs, fever, crusty eyes, shortness of breath
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fluid retention, Heart rate increased, Pyrexia, SARS-CoV-2 test
Clinical narrative: Rapid heart rate, explosive cough that made me pee, chest pain, extreme fatigue, i felt like I had liquid in my lungs, fever, crusty eyes, shortness of breath
Age: 53.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Arthralgia, Blood test, Feeling abnormal, Mobility decreased, Myalgia
Clinical narrative: I don't know which TDaP I received. It has been 28 hours since my injection and I feel like I've been hit by a truck. I have felt miserable all day. Both arms are incredibly sore, and all my muscles and joints ache. Tylenol barely takes the edge off. I haven't been able to get out of bed all day.
Age: 53.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Pain in extremity
Clinical narrative: I don't know which TDaP I received. It has been 28 hours since my injection and I feel like I've been hit by a truck. I have felt miserable all day. Both arms are incredibly sore, and all my muscles and joints ache. Tylenol barely takes the edge off. I haven't been able to get out of bed all day.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Bursitis, Injection site pain, Pain, Shoulder injury related to vaccine administration, Swelling
Clinical narrative: Shoulder injury related to vaccine administration.  subacromial bursitis. Left shoulder joint. Description: after 2nd dose of Pfizer, Left arm was very sore at injection site, but it was just sore like after getting a tetanus shot but higher pain and quite swollen.  The soreness and swelling subsided over approx a week.  But then the pain at the injection site came back.  It was marked and constant by the beginning of April 2021.  The pain at the injection site continued, at various levels (significant but usually mild), for many months.  Finally, in November, I sought medical care.  This was to see if there was any concern about my reaction, and whether I should get the booster and if so, which brand and in what arm.  My primary care physician referred me to a specialist (sports medicine).  He performed an ultrasound and provided the diagnosis. He injected the shoulder with Kenalog.  The Kenalog  helped some, but the injection site is still sore to this day (almost 12 months since receiving my second Pfizer dose).  Note: my first dose was Pfizer in the left arm on Feb 15 2021, after which my injection site and shoulder felt fine.  My second Pfizer dose was in the left arm March 8 2021, after which the reported pain developed and persists.  I received a Moderna booster in my Right Arm in November 2021; my right arm is fine at this time .
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: Shoulder injury related to vaccine administration.  subacromial bursitis. Left shoulder joint. Description: after 2nd dose of Pfizer, Left arm was very sore at injection site, but it was just sore like after getting a tetanus shot but higher pain and quite swollen.  The soreness and swelling subsided over approx a week.  But then the pain at the injection site came back.  It was marked and constant by the beginning of April 2021.  The pain at the injection site continued, at various levels (significant but usually mild), for many months.  Finally, in November, I sought medical care.  This was to see if there was any concern about my reaction, and whether I should get the booster and if so, which brand and in what arm.  My primary care physician referred me to a specialist (sports medicine).  He performed an ultrasound and provided the diagnosis. He injected the shoulder with Kenalog.  The Kenalog  helped some, but the injection site is still sore to this day (almost 12 months since receiving my second Pfizer dose).  Note: my first dose was Pfizer in the left arm on Feb 15 2021, after which my injection site and shoulder felt fine.  My second Pfizer dose was in the left arm March 8 2021, after which the reported pain developed and persists.  I received a Moderna booster in my Right Arm in November 2021; my right arm is fine at this time .
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: Child was administered his second COVID vaccine on 2/15/2022/ The vaccine given had NO diluent added, making it 1.5x dose. Patient was observed for 30 minutes in office without any symptoms.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Chest X-ray, Chills, Computerised tomogram normal, Dizziness
Clinical narrative: 15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fall, Fatigue, Feeling abnormal, Hot flush
Clinical narrative: 15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Illness, Magnetic resonance imaging, Magnetic resonance imaging head, Malaise
Clinical narrative: 15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Muscle spasms, Muscular weakness, Nausea, Onycholysis
Clinical narrative: 15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tinnitus, Ultrasound scan, Vestibular disorder, Vision blurred
Clinical narrative: 15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Walking aid user
Clinical narrative: 15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Headache; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021302243.  A 58 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 22Apr2021 10:45 (Lot number: EW0153) at the age of 58 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing); "Ovarian cyst" (unspecified if ongoing); "Seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: TOPROL taken for blood pressure abnormal (ongoing); METFORMIN taken for ovarian cyst (ongoing); ZYRTEC [CETIRIZINE HYDROCHLORIDE] taken for seasonal allergy (ongoing). Vaccination history included: Bnt162b2 (Dose 1, single, Time: 09:30 am, Anatomical Site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: Lot EN6207, ), administration date: 16Mar2021, for COVID-19 Immunization, reaction(s): "Pressure in ear", "Neck tingle", "Tired", "Headache", "Ear red", "Splotches, rash on chest", "Rash possible side effect", "Shingles". The following information was reported: HEADACHE (non-serious) with onset 23Apr2021, outcome "recovered" (24Apr2021), described as "Headache"; CHILLS (non-serious) with onset 23Apr2021, outcome "recovered" (24Apr2021), described as "Chills".  Additional Information: The events onset latency was 13 hrs 15 min after vaccination.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: severe dizziness / light headed; room spinning; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 66 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 14Feb2021 17:00 (Lot number: EN6201) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Basal cell carcinoma", start date: May1997, stop date: Jun2019; "Osteoporosis", start date: Jun2019 (ongoing); "Skin R arm removed" (unspecified if ongoing); "Abdominal Bruit" (unspecified if ongoing). Concomitant medication(s) included: LIPITONE taken for abdominal bruit (ongoing); ASA taken for abdominal bruit (ongoing). The following information was reported: DIZZINESS (non-serious) with onset 15Feb2021, outcome "recovered" (Feb2021), described as "severe dizziness / light headed"; VERTIGO (non-serious) with onset 15Feb2021, outcome "recovered" (Feb2021), described as "room spinning". Therapeutic measures were not taken as a result of dizziness, vertigo.  Additional information: It was further reported that the patient was exercising weight lifting and experienced severe dizziness, room spinning, and light headed. Patient do this series of exercise almost daily and had never experienced these symptoms. Dizziness lasted approximately 3 to 4 hours. The patient received the second dose of BNT162B2 (Lot number: EN6206) intramuscularly in the left arm on 07Mar2021 at 17:00.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Biopsy pancreas abnormal, Bone cancer, Brain cancer metastatic, Chest X-ray
Clinical narrative: 3/4/21  first dose of moderna vaccine 3/11/21 one week after vaccine - begin with significant persistent abdominal pain and headaches 4/1/21 second dose of moderna vaccine 4/13/21 less than two weeks after vaccine significant wheezing  4/14/21 Ultrasound of abdomen 4/15/21 MRI of abdomen 4/21/21 xray of lung 4/23/21 CT of lungs 4/24/21 Biopsy of pancreas (revealed small cell cancer)   4/25/21 admitted for pancreatitis (caused by biopsy procedure) 5/3/21 face drooping on one side (brain CT revealed mass on brain) 5/10/21 passed away  In the hospital there were numerous CTs, Xrays, and Ultrasounds for various reasons. Cancer was found on the pancreas, lungs, bone, brain.  While I am not convinced that the vaccine caused the cancer, I am definitely not ruling it out.  I am convinced that the vaccine prohibited the body's natural response to fight the cancer or it caused it to "flare up" or "ignited it".   Patient was a healthy active man until he received the vaccine. Then suddenly one week later he had pain in his abdomen and head and had trouble breathing. Then within two months he is deceased.  The probability of having cancer show symptoms in three places suddenly at the same time seems extremely unlikely unless something triggered it.  While patient was a proponent of getting the vaccine, after getting it he repeatedly said that it made him sick.  Does data show a rise in cancer statistics (diagnosis and deaths) since Covid vaccines were administered?
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Computerised tomogram thorax, Death, Dyspnoea, Facial paralysis
Clinical narrative: 3/4/21  first dose of moderna vaccine 3/11/21 one week after vaccine - begin with significant persistent abdominal pain and headaches 4/1/21 second dose of moderna vaccine 4/13/21 less than two weeks after vaccine significant wheezing  4/14/21 Ultrasound of abdomen 4/15/21 MRI of abdomen 4/21/21 xray of lung 4/23/21 CT of lungs 4/24/21 Biopsy of pancreas (revealed small cell cancer)   4/25/21 admitted for pancreatitis (caused by biopsy procedure) 5/3/21 face drooping on one side (brain CT revealed mass on brain) 5/10/21 passed away  In the hospital there were numerous CTs, Xrays, and Ultrasounds for various reasons. Cancer was found on the pancreas, lungs, bone, brain.  While I am not convinced that the vaccine caused the cancer, I am definitely not ruling it out.  I am convinced that the vaccine prohibited the body's natural response to fight the cancer or it caused it to "flare up" or "ignited it".   Patient was a healthy active man until he received the vaccine. Then suddenly one week later he had pain in his abdomen and head and had trouble breathing. Then within two months he is deceased.  The probability of having cancer show symptoms in three places suddenly at the same time seems extremely unlikely unless something triggered it.  While patient was a proponent of getting the vaccine, after getting it he repeatedly said that it made him sick.  Does data show a rise in cancer statistics (diagnosis and deaths) since Covid vaccines were administered?
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Intracranial mass, Lung neoplasm malignant, Magnetic resonance imaging abdominal, Malaise
Clinical narrative: 3/4/21  first dose of moderna vaccine 3/11/21 one week after vaccine - begin with significant persistent abdominal pain and headaches 4/1/21 second dose of moderna vaccine 4/13/21 less than two weeks after vaccine significant wheezing  4/14/21 Ultrasound of abdomen 4/15/21 MRI of abdomen 4/21/21 xray of lung 4/23/21 CT of lungs 4/24/21 Biopsy of pancreas (revealed small cell cancer)   4/25/21 admitted for pancreatitis (caused by biopsy procedure) 5/3/21 face drooping on one side (brain CT revealed mass on brain) 5/10/21 passed away  In the hospital there were numerous CTs, Xrays, and Ultrasounds for various reasons. Cancer was found on the pancreas, lungs, bone, brain.  While I am not convinced that the vaccine caused the cancer, I am definitely not ruling it out.  I am convinced that the vaccine prohibited the body's natural response to fight the cancer or it caused it to "flare up" or "ignited it".   Patient was a healthy active man until he received the vaccine. Then suddenly one week later he had pain in his abdomen and head and had trouble breathing. Then within two months he is deceased.  The probability of having cancer show symptoms in three places suddenly at the same time seems extremely unlikely unless something triggered it.  While patient was a proponent of getting the vaccine, after getting it he repeatedly said that it made him sick.  Does data show a rise in cancer statistics (diagnosis and deaths) since Covid vaccines were administered?
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pancreatic carcinoma, Pancreatitis, Post procedural complication, Ultrasound abdomen, Wheezing
Clinical narrative: 3/4/21  first dose of moderna vaccine 3/11/21 one week after vaccine - begin with significant persistent abdominal pain and headaches 4/1/21 second dose of moderna vaccine 4/13/21 less than two weeks after vaccine significant wheezing  4/14/21 Ultrasound of abdomen 4/15/21 MRI of abdomen 4/21/21 xray of lung 4/23/21 CT of lungs 4/24/21 Biopsy of pancreas (revealed small cell cancer)   4/25/21 admitted for pancreatitis (caused by biopsy procedure) 5/3/21 face drooping on one side (brain CT revealed mass on brain) 5/10/21 passed away  In the hospital there were numerous CTs, Xrays, and Ultrasounds for various reasons. Cancer was found on the pancreas, lungs, bone, brain.  While I am not convinced that the vaccine caused the cancer, I am definitely not ruling it out.  I am convinced that the vaccine prohibited the body's natural response to fight the cancer or it caused it to "flare up" or "ignited it".   Patient was a healthy active man until he received the vaccine. Then suddenly one week later he had pain in his abdomen and head and had trouble breathing. Then within two months he is deceased.  The probability of having cancer show symptoms in three places suddenly at the same time seems extremely unlikely unless something triggered it.  While patient was a proponent of getting the vaccine, after getting it he repeatedly said that it made him sick.  Does data show a rise in cancer statistics (diagnosis and deaths) since Covid vaccines were administered?
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal behaviour, Bone pain, Computerised tomogram, Cyanosis, Electrocardiogram
Clinical narrative: About 30 mins after receiving the vaccine he felt weird, hurting all over, in his bones.  Slept most of the rest of the day for feeling bad.  Was watching the fights and had 4 beers over a 5 hour time frame.  Sent him out to grab me a soda out of the cooler and he never came back in.  Found him unconscious in the drive way laying in a 24" section perfectly laid out like in his casket.  Tail gate on truck was down and cooler pulled out but no soda anywhere.  Took a few minutes to bring him to....had a quarter sized area on the back of his head that was skinned up but no knot or lump.  He was a little loopy so I made sure to keep him awake for 3 1/2 hours.  I dozed off for about 15 minutes and when I awoke his eyes were all black and blue, swollen.  Took him to ER, they did a CT and had trauma unit from downtown come pick him up.  Spent the next 30 days going through hell and he is still not right.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Electroencephalogram, Eye contusion, Feeling abnormal, Hypersomnia, Loss of consciousness
Clinical narrative: About 30 mins after receiving the vaccine he felt weird, hurting all over, in his bones.  Slept most of the rest of the day for feeling bad.  Was watching the fights and had 4 beers over a 5 hour time frame.  Sent him out to grab me a soda out of the cooler and he never came back in.  Found him unconscious in the drive way laying in a 24" section perfectly laid out like in his casket.  Tail gate on truck was down and cooler pulled out but no soda anywhere.  Took a few minutes to bring him to....had a quarter sized area on the back of his head that was skinned up but no knot or lump.  He was a little loopy so I made sure to keep him awake for 3 1/2 hours.  I dozed off for about 15 minutes and when I awoke his eyes were all black and blue, swollen.  Took him to ER, they did a CT and had trauma unit from downtown come pick him up.  Spent the next 30 days going through hell and he is still not right.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Pain, Skin laceration, Swelling of eyelid
Clinical narrative: About 30 mins after receiving the vaccine he felt weird, hurting all over, in his bones.  Slept most of the rest of the day for feeling bad.  Was watching the fights and had 4 beers over a 5 hour time frame.  Sent him out to grab me a soda out of the cooler and he never came back in.  Found him unconscious in the drive way laying in a 24" section perfectly laid out like in his casket.  Tail gate on truck was down and cooler pulled out but no soda anywhere.  Took a few minutes to bring him to....had a quarter sized area on the back of his head that was skinned up but no knot or lump.  He was a little loopy so I made sure to keep him awake for 3 1/2 hours.  I dozed off for about 15 minutes and when I awoke his eyes were all black and blue, swollen.  Took him to ER, they did a CT and had trauma unit from downtown come pick him up.  Spent the next 30 days going through hell and he is still not right.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac stress test, Condition aggravated, Dyspnoea, Echocardiogram, Loss of personal independence in daily activities
Clinical narrative: Received injection on Tuesday, August 24, 2021.  On Saturday, August 28, 2021, I experienced a significant increase in muscle fatigue associated with the Myasthenia Gravis over previous days.  This was sustained (and has remained sustained) since that time.  This includes muscle fatigue that impacts performance of basic ADLs (washing hair, brushing teeth, etc.), as well as increased muscle fatigue over previous experience during and following mild exercise routine.  This has resulted in use of Tylenol and/or Advil to relieve the ongoing fatigue associated with the post exercise discomfort.  Use increased from 1 - 2 times monthly to 3 - 5 times a week to relieve the discomfort.  Additionally, I experienced a sense of not getting enough oxygen, resulting in taking large breathes multiple times during the day.  I also experienced an inability to complete sentences without taking an additional breath.  This represented a significant change from my respiratory pattern.  Changes in my respiratory status were noticed by my peers in the workplace as well as my wife.  Following this experience, I discussed these changes with my Neurologist on 10/7/21 who ordered a Cardiac Echo which was performed on 10/13/21.  Additionally, I saw my PCP who ordered a Stress Echo which was performed on 10/29/21.  The Stress Echo indicated the presence of pulmonary hypertension, a condition for which I have never been diagnosed previously.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle fatigue, Myasthenia gravis
Clinical narrative: Received injection on Tuesday, August 24, 2021.  On Saturday, August 28, 2021, I experienced a significant increase in muscle fatigue associated with the Myasthenia Gravis over previous days.  This was sustained (and has remained sustained) since that time.  This includes muscle fatigue that impacts performance of basic ADLs (washing hair, brushing teeth, etc.), as well as increased muscle fatigue over previous experience during and following mild exercise routine.  This has resulted in use of Tylenol and/or Advil to relieve the ongoing fatigue associated with the post exercise discomfort.  Use increased from 1 - 2 times monthly to 3 - 5 times a week to relieve the discomfort.  Additionally, I experienced a sense of not getting enough oxygen, resulting in taking large breathes multiple times during the day.  I also experienced an inability to complete sentences without taking an additional breath.  This represented a significant change from my respiratory pattern.  Changes in my respiratory status were noticed by my peers in the workplace as well as my wife.  Following this experience, I discussed these changes with my Neurologist on 10/7/21 who ordered a Cardiac Echo which was performed on 10/13/21.  Additionally, I saw my PCP who ordered a Stress Echo which was performed on 10/29/21.  The Stress Echo indicated the presence of pulmonary hypertension, a condition for which I have never been diagnosed previously.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: Develop tinnitus which at almost a year later has not gone away
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram normal, Computerised tomogram normal, Depressed level of consciousness, Electroencephalogram abnormal, Encephalitis autoimmune
Clinical narrative: Post-vaccination, pt first had headache and then overall malaise, low grade fever, lethargy, rapidly progressing to becoming obtuned. Transferred to Hospital - started on plasmapheresis for autoimmune encephalitis, treated empirically with antitoxins for possible botulism and with antibiotics. Then transferred, where pt developed L tension ptx presumably related to dislodged ETT with re-tubation enroute. On Dec 7, 2021 pt was transferred to a specialty hospital - no records.   Presented to hospital on Jan 27, 2022 with hx of bilateral lower extremity paralysis, dx as GBS.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Encephalopathy, Endotracheal intubation, Endotracheal intubation complication, Guillain-Barre syndrome, Headache
Clinical narrative: Post-vaccination, pt first had headache and then overall malaise, low grade fever, lethargy, rapidly progressing to becoming obtuned. Transferred to Hospital - started on plasmapheresis for autoimmune encephalitis, treated empirically with antitoxins for possible botulism and with antibiotics. Then transferred, where pt developed L tension ptx presumably related to dislodged ETT with re-tubation enroute. On Dec 7, 2021 pt was transferred to a specialty hospital - no records.   Presented to hospital on Jan 27, 2022 with hx of bilateral lower extremity paralysis, dx as GBS.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Magnetic resonance imaging normal, Malaise, Monoplegia, Plasmapheresis
Clinical narrative: Post-vaccination, pt first had headache and then overall malaise, low grade fever, lethargy, rapidly progressing to becoming obtuned. Transferred to Hospital - started on plasmapheresis for autoimmune encephalitis, treated empirically with antitoxins for possible botulism and with antibiotics. Then transferred, where pt developed L tension ptx presumably related to dislodged ETT with re-tubation enroute. On Dec 7, 2021 pt was transferred to a specialty hospital - no records.   Presented to hospital on Jan 27, 2022 with hx of bilateral lower extremity paralysis, dx as GBS.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumothorax, Pyrexia
Clinical narrative: Post-vaccination, pt first had headache and then overall malaise, low grade fever, lethargy, rapidly progressing to becoming obtuned. Transferred to Hospital - started on plasmapheresis for autoimmune encephalitis, treated empirically with antitoxins for possible botulism and with antibiotics. Then transferred, where pt developed L tension ptx presumably related to dislodged ETT with re-tubation enroute. On Dec 7, 2021 pt was transferred to a specialty hospital - no records.   Presented to hospital on Jan 27, 2022 with hx of bilateral lower extremity paralysis, dx as GBS.
Sex: M
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT ISCHAEMIC ATTACK; This spontaneous report received from a patient via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAERS ID: 1849799) via a company representative concerned a 5 decade (around 41 years) male of unknown ethnicity.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, and expiry: unknown) dose, start therapy date were not reported, 01 total was administered for prophylactic vaccination. All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided. No concomitant medications were reported.  On an unspecified date, the patient experienced transient ischaemic attack. The timing between the vaccine and the stroke was unknown, and that the patient still had troubled speaking today.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient had not recovered from transient ischaemic attack.  This report was serious (Other Medically Important Condition).   Additional information was received on 22-FEB-2022. All required follow-up attempts have been made. The Batch number for covid-19 vaccine ad26.cov2.s has not been provided.; Sender's Comments: V4:Additional information was received on 22-FEB-2022. All required follow-up attempts have been made. The Batch number for covid-19 vaccine ad26.cov2.s has not been provided. This updated information does not alter the causality of previously reported events. 20211112429-Covid-19 vaccine ad26.cov2.s-transient ischaemic attack- This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Bone pain, Chest pain, Palpitations
Clinical narrative: Heart palipations foe several weeks; Chronic chest pain; Chronic sternum pain; back pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Dec2021 (Lot number: FJ1620) at the age of 40 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0158), administration date: 11Apr2021, when the patient was 40 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8727), administration date: 21Mar2021, when the patient was 40 years old, for COVID-19 Immunization. The following information was reported: PALPITATIONS (non-serious) with onset 14Dec2021, outcome "not recovered", described as "Heart palipations foe several weeks"; CHEST PAIN (non-serious) with onset 14Dec2021, outcome "not recovered", described as "Chronic chest pain"; BONE PAIN (non-serious) with onset 14Dec2021, outcome "not recovered", described as "Chronic sternum pain"; BACK PAIN (non-serious) with onset 14Dec2021, outcome "not recovered", described as "back pain". The events "heart palipations foe several weeks", "chronic chest pain", "chronic sternum pain" and "back pain" were evaluated at the physician office visit and emergency room visit. It was unknown if therapeutic measures were taken as a result of palpitations, chest pain, bone pain, back pain.  Additional information: No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Osteolysis, Pathological fracture, Periprosthetic fracture, SARS-CoV-2 test positive
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Appendicitis, Blood test, COVID-19, Computerised tomogram, Pain
Clinical narrative: severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there; severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there; Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2; Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2; Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2; she tested positive for Covid 3 days later; she tested positive for Covid 3 days later; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 03Jan2022 14:00 (Lot number: FS1611) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Moderna (Dose:1, Lot:04QA21A), administration date: 15Mar2021, when the patient was 49 years old, for COVID-19 Immunization; Moderna (Dose:2, Lot:016B21A), administration date: 15Apr2021, when the patient was 49 years old, for COVID-19 Immunization.  The following information was reported: APPENDIX DISORDER (hospitalization) with onset 14Jan2022, outcome "recovering", described as "severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Jan2022, outcome "unknown" and all described as "she tested positive for Covid 3 days later"; OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 03Jan2022 14:00, outcome "unknown" and all described as "Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2". The patient was hospitalized for appendix disorder (start date: 14Jan2022, discharge date: 16Jan2022, hospitalization duration: 2 day(s)).   The event "severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there" was evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06Jan2022) positive. Therapeutic measures were taken as a result of appendix disorder. Therapeutic measures were taken with Surgery to remove appendix, IV antibiotic and oral antibiotics post discharge. She recovered a week to a week and half later, but she was a month out and she still had some soreness and was healing. She took vaccine for prevention from Covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Appendicitis perforated, COVID-19, Complicated appendicitis, Drug ineffective, Immunisation
Clinical narrative: severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there; severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there; Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2; Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2; Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2; she tested positive for Covid 3 days later; she tested positive for Covid 3 days later; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 03Jan2022 14:00 (Lot number: FS1611) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Moderna (Dose:1, Lot:04QA21A), administration date: 15Mar2021, when the patient was 49 years old, for COVID-19 Immunization; Moderna (Dose:2, Lot:016B21A), administration date: 15Apr2021, when the patient was 49 years old, for COVID-19 Immunization.  The following information was reported: APPENDIX DISORDER (hospitalization) with onset 14Jan2022, outcome "recovering", described as "severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Jan2022, outcome "unknown" and all described as "she tested positive for Covid 3 days later"; OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 03Jan2022 14:00, outcome "unknown" and all described as "Dose 1: Moderna, Dose 2: Moderna; Dose 3: BNT162B2". The patient was hospitalized for appendix disorder (start date: 14Jan2022, discharge date: 16Jan2022, hospitalization duration: 2 day(s)).   The event "severe pain in her side, which turned into an almost ruptured appendix; perforated appendix and gangrene in there" was evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06Jan2022) positive. Therapeutic measures were taken as a result of appendix disorder. Therapeutic measures were taken with Surgery to remove appendix, IV antibiotic and oral antibiotics post discharge. She recovered a week to a week and half later, but she was a month out and she still had some soreness and was healing. She took vaccine for prevention from Covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.